Cargando…
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies
Metastatic events to the bone occur frequently in numerous cancer types such as breast, prostate, lung, and renal carcinomas, melanoma, neuroblastoma, and multiple myeloma. Accumulating evidence suggests that the inflammatory cytokine interleukin (IL)-6 is frequently upregulated and is implicated in...
Autores principales: | Tawara, Ken, Oxford, Julia T, Jorcyk, Cheryl L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101113/ https://www.ncbi.nlm.nih.gov/pubmed/21625400 http://dx.doi.org/10.2147/CMR.S18101 |
Ejemplares similares
-
IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
por: Browning, Landon, et al.
Publicado: (2018) -
HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β
por: Tawara, Ken, et al.
Publicado: (2019) -
Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology
por: Mikelonis, Dawn, et al.
Publicado: (2014) -
Endoplasmic Reticulum Stress and Unfolded Protein Response in Cartilage Pathophysiology; Contributing Factors to Apoptosis and Osteoarthritis
por: Hughes, Alexandria, et al.
Publicado: (2017) -
Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion()()
por: Tawara, Ken, et al.
Publicado: (2018)